Abnormal immune responses of the innate immune system can cause autoimmune diseases, which can damage body tissues and lead to abnormal organ functions. Immunological complications due to physiological processes within the human body lead to autoimmune diseases. These diseases are characterized by chronic inflammatory processes that activate the innate immune system and the production of antibodies that destroy host tissues. These inflammatory processes can be caused by genetic or environmental factors or infections.
In 2019, the market size of Autoimmune Drugs is xx million US$ and it will reach xx million US$ in 2025, growing at a CAGR of xx% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Autoimmune Drugs.
This report studies the global market size of Autoimmune Drugs, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
This study presents the Autoimmune Drugs sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sales, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.
In global market, the following companies are covered:
Eli Lilly
GSK
AbbVie
Johnson & Johnson
Biogen
Amgen
Pfizer
Roche
Baxter
Market Segment by Product Type
Rheumatoid Arthritis (RA)
Multiple Sclerosis (MS)
Psoriasis
Inflammatory Bowel Disease (IBD)
Ankylosing Spondylitis (AS)
Systemic Lupus Erythematosus (SLE)
Market Segment by Application
Hospitals
Homecare Settings
Specialty Clinics
Key Regions split in this report: breakdown data for each region.
United States
China
European Union
Rest of World (Japan, Korea, India and Southeast Asia)
The study objectives are:
To analyze and research the Autoimmune Drugs status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
To present the key Autoimmune Drugs manufacturers, presenting the sales, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
In this study, the years considered to estimate the market size of Autoimmune Drugs are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
In 2019, the market size of Autoimmune Drugs is xx million US$ and it will reach xx million US$ in 2025, growing at a CAGR of xx% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Autoimmune Drugs.
This report studies the global market size of Autoimmune Drugs, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
This study presents the Autoimmune Drugs sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sales, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.
In global market, the following companies are covered:
Eli Lilly
GSK
AbbVie
Johnson & Johnson
Biogen
Amgen
Pfizer
Roche
Baxter
Market Segment by Product Type
Rheumatoid Arthritis (RA)
Multiple Sclerosis (MS)
Psoriasis
Inflammatory Bowel Disease (IBD)
Ankylosing Spondylitis (AS)
Systemic Lupus Erythematosus (SLE)
Market Segment by Application
Hospitals
Homecare Settings
Specialty Clinics
Key Regions split in this report: breakdown data for each region.
United States
China
European Union
Rest of World (Japan, Korea, India and Southeast Asia)
The study objectives are:
To analyze and research the Autoimmune Drugs status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
To present the key Autoimmune Drugs manufacturers, presenting the sales, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
In this study, the years considered to estimate the market size of Autoimmune Drugs are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Major Manufacturers Covered in This Report
1.3 Market Segment by Type
1.3.1 Global Autoimmune Drugs Market Size Growth Rate by Type (2019-2025)
1.3.2 Rheumatoid Arthritis (RA)
1.3.3 Multiple Sclerosis (MS)
1.3.4 Psoriasis
1.3.5 Inflammatory Bowel Disease (IBD)
1.3.6 Ankylosing Spondylitis (AS)
1.3.7 Systemic Lupus Erythematosus (SLE)
1.4 Market Segment by Application
1.4.1 Global Autoimmune Drugs Market Share by Application (2019-2025)
1.4.2 Hospitals
1.4.3 Homecare Settings
1.4.4 Specialty Clinics
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Autoimmune Drugs Market Size
2.1.1 Global Autoimmune Drugs Revenue 2014-2025
2.1.2 Global Autoimmune Drugs Sales 2014-2025
2.2 Autoimmune Drugs Growth Rate by Regions
2.2.1 Global Autoimmune Drugs Sales by Regions 2014-2019
2.2.2 Global Autoimmune Drugs Revenue by Regions 2014-2019
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
3 Market Share by Manufacturers
3.1 Autoimmune Drugs Sales by Manufacturers
3.1.1 Autoimmune Drugs Sales by Manufacturers 2014-2019
3.1.2 Autoimmune Drugs Sales Market Share by Manufacturers 2014-2019
3.2 Revenue by Manufacturers
3.2.1 Autoimmune Drugs Revenue by Manufacturers (2014-2019)
3.2.2 Autoimmune Drugs Revenue Share by Manufacturers (2014-2019)
3.2.3 Global Autoimmune Drugs Market Concentration Ratio (CR5 and HHI)
3.3 Autoimmune Drugs Price by Manufacturers
3.4 Key Manufacturers Autoimmune Drugs Plants/Factories Distribution and Area Served
3.5 Date of Key Manufacturers Enter into Autoimmune Drugs Market
3.6 Key Manufacturers Autoimmune Drugs Product Offered
3.7 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Sales and Revenue for Each Type
4.1.1 Rheumatoid Arthritis (RA) Sales and Revenue (2014-2019)
4.1.2 Multiple Sclerosis (MS) Sales and Revenue (2014-2019)
4.1.3 Psoriasis Sales and Revenue (2014-2019)
4.1.4 Inflammatory Bowel Disease (IBD) Sales and Revenue (2014-2019)
4.1.5 Ankylosing Spondylitis (AS) Sales and Revenue (2014-2019)
4.1.6 Systemic Lupus Erythematosus (SLE) Sales and Revenue (2014-2019)
4.2 Global Autoimmune Drugs Sales Market Share by Type
4.3 Global Autoimmune Drugs Revenue Market Share by Type
4.4 Autoimmune Drugs Price by Type
5 Market Size by Application
5.1 Overview
5.2 Global Autoimmune Drugs Sales by Application
6 United States
6.1 United States Autoimmune Drugs Breakdown Data by Company
6.2 United States Autoimmune Drugs Breakdown Data by Type
6.3 United States Autoimmune Drugs Breakdown Data by Application
7 European Union
7.1 European Union Autoimmune Drugs Breakdown Data by Company
7.2 European Union Autoimmune Drugs Breakdown Data by Type
7.3 European Union Autoimmune Drugs Breakdown Data by Application
8 China
8.1 China Autoimmune Drugs Breakdown Data by Company
8.2 China Autoimmune Drugs Breakdown Data by Type
8.3 China Autoimmune Drugs Breakdown Data by Application
9 Rest of World
9.1 Rest of World Autoimmune Drugs Breakdown Data by Company
9.2 Rest of World Autoimmune Drugs Breakdown Data by Type
9.3 Rest of World Autoimmune Drugs Breakdown Data by Application
9.4 Rest of World Autoimmune Drugs Breakdown Data by Countries
9.4.1 Rest of World Autoimmune Drugs Sales by Countries
9.4.2 Rest of World Autoimmune Drugs Revenue by Countries
9.4.3 Japan
9.4.4 Korea
9.4.5 India
9.4.6 Southeast Asia
10 Company Profiles
10.1 Eli Lilly
10.1.1 Eli Lilly Company Details
10.1.2 Company Description and Business Overview
10.1.3 Sales, Revenue and Market Share of Autoimmune Drugs
10.1.4 Autoimmune Drugs Product Introduction
10.1.5 Eli Lilly Recent Development
10.2 GSK
10.2.1 GSK Company Details
10.2.2 Company Description and Business Overview
10.2.3 Sales, Revenue and Market Share of Autoimmune Drugs
10.2.4 Autoimmune Drugs Product Introduction
10.2.5 GSK Recent Development
10.3 AbbVie
10.3.1 AbbVie Company Details
10.3.2 Company Description and Business Overview
10.3.3 Sales, Revenue and Market Share of Autoimmune Drugs
10.3.4 Autoimmune Drugs Product Introduction
10.3.5 AbbVie Recent Development
10.4 Johnson & Johnson
10.4.1 Johnson & Johnson Company Details
10.4.2 Company Description and Business Overview
10.4.3 Sales, Revenue and Market Share of Autoimmune Drugs
10.4.4 Autoimmune Drugs Product Introduction
10.4.5 Johnson & Johnson Recent Development
10.5 Biogen
10.5.1 Biogen Company Details
10.5.2 Company Description and Business Overview
10.5.3 Sales, Revenue and Market Share of Autoimmune Drugs
10.5.4 Autoimmune Drugs Product Introduction
10.5.5 Biogen Recent Development
10.6 Amgen
10.6.1 Amgen Company Details
10.6.2 Company Description and Business Overview
10.6.3 Sales, Revenue and Market Share of Autoimmune Drugs
10.6.4 Autoimmune Drugs Product Introduction
10.6.5 Amgen Recent Development
10.7 Pfizer
10.7.1 Pfizer Company Details
10.7.2 Company Description and Business Overview
10.7.3 Sales, Revenue and Market Share of Autoimmune Drugs
10.7.4 Autoimmune Drugs Product Introduction
10.7.5 Pfizer Recent Development
10.8 Roche
10.8.1 Roche Company Details
10.8.2 Company Description and Business Overview
10.8.3 Sales, Revenue and Market Share of Autoimmune Drugs
10.8.4 Autoimmune Drugs Product Introduction
10.8.5 Roche Recent Development
10.9 Baxter
10.9.1 Baxter Company Details
10.9.2 Company Description and Business Overview
10.9.3 Sales, Revenue and Market Share of Autoimmune Drugs
10.9.4 Autoimmune Drugs Product Introduction
10.9.5 Baxter Recent Development
11 Value Chain and Sales Channels Analysis
11.1 Value Chain Analysis
11.2 Sales Channels Analysis
11.2.1 Autoimmune Drugs Sales Channels
11.2.2 Autoimmune Drugs Distributors
11.3 Autoimmune Drugs Customers
12 Market Forecast
12.1 Global Autoimmune Drugs Sales and Revenue Forecast 2019-2025
12.2 Global Autoimmune Drugs Sales Forecast by Type
12.3 Global Autoimmune Drugs Sales Forecast by Application
12.4 Autoimmune Drugs Forecast by Regions
12.4.1 Global Autoimmune Drugs Sales Forecast by Regions 2019-2025
12.4.2 Global Autoimmune Drugs Revenue Forecast by Regions 2019-2025
12.5 United States Market Forecast
12.6 European Union Market Forecast
12.7 China Market Forecast
12.8 Rest of World
12.8.1 Japan
12.8.2 Korea
12.8.3 India
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer
1 Report Overview
1.1 Study Scope
1.2 Major Manufacturers Covered in This Report
1.3 Market Segment by Type
1.3.1 Global Autoimmune Drugs Market Size Growth Rate by Type (2019-2025)
1.3.2 Rheumatoid Arthritis (RA)
1.3.3 Multiple Sclerosis (MS)
1.3.4 Psoriasis
1.3.5 Inflammatory Bowel Disease (IBD)
1.3.6 Ankylosing Spondylitis (AS)
1.3.7 Systemic Lupus Erythematosus (SLE)
1.4 Market Segment by Application
1.4.1 Global Autoimmune Drugs Market Share by Application (2019-2025)
1.4.2 Hospitals
1.4.3 Homecare Settings
1.4.4 Specialty Clinics
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Autoimmune Drugs Market Size
2.1.1 Global Autoimmune Drugs Revenue 2014-2025
2.1.2 Global Autoimmune Drugs Sales 2014-2025
2.2 Autoimmune Drugs Growth Rate by Regions
2.2.1 Global Autoimmune Drugs Sales by Regions 2014-2019
2.2.2 Global Autoimmune Drugs Revenue by Regions 2014-2019
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
3 Market Share by Manufacturers
3.1 Autoimmune Drugs Sales by Manufacturers
3.1.1 Autoimmune Drugs Sales by Manufacturers 2014-2019
3.1.2 Autoimmune Drugs Sales Market Share by Manufacturers 2014-2019
3.2 Revenue by Manufacturers
3.2.1 Autoimmune Drugs Revenue by Manufacturers (2014-2019)
3.2.2 Autoimmune Drugs Revenue Share by Manufacturers (2014-2019)
3.2.3 Global Autoimmune Drugs Market Concentration Ratio (CR5 and HHI)
3.3 Autoimmune Drugs Price by Manufacturers
3.4 Key Manufacturers Autoimmune Drugs Plants/Factories Distribution and Area Served
3.5 Date of Key Manufacturers Enter into Autoimmune Drugs Market
3.6 Key Manufacturers Autoimmune Drugs Product Offered
3.7 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Sales and Revenue for Each Type
4.1.1 Rheumatoid Arthritis (RA) Sales and Revenue (2014-2019)
4.1.2 Multiple Sclerosis (MS) Sales and Revenue (2014-2019)
4.1.3 Psoriasis Sales and Revenue (2014-2019)
4.1.4 Inflammatory Bowel Disease (IBD) Sales and Revenue (2014-2019)
4.1.5 Ankylosing Spondylitis (AS) Sales and Revenue (2014-2019)
4.1.6 Systemic Lupus Erythematosus (SLE) Sales and Revenue (2014-2019)
4.2 Global Autoimmune Drugs Sales Market Share by Type
4.3 Global Autoimmune Drugs Revenue Market Share by Type
4.4 Autoimmune Drugs Price by Type
5 Market Size by Application
5.1 Overview
5.2 Global Autoimmune Drugs Sales by Application
6 United States
6.1 United States Autoimmune Drugs Breakdown Data by Company
6.2 United States Autoimmune Drugs Breakdown Data by Type
6.3 United States Autoimmune Drugs Breakdown Data by Application
7 European Union
7.1 European Union Autoimmune Drugs Breakdown Data by Company
7.2 European Union Autoimmune Drugs Breakdown Data by Type
7.3 European Union Autoimmune Drugs Breakdown Data by Application
8 China
8.1 China Autoimmune Drugs Breakdown Data by Company
8.2 China Autoimmune Drugs Breakdown Data by Type
8.3 China Autoimmune Drugs Breakdown Data by Application
9 Rest of World
9.1 Rest of World Autoimmune Drugs Breakdown Data by Company
9.2 Rest of World Autoimmune Drugs Breakdown Data by Type
9.3 Rest of World Autoimmune Drugs Breakdown Data by Application
9.4 Rest of World Autoimmune Drugs Breakdown Data by Countries
9.4.1 Rest of World Autoimmune Drugs Sales by Countries
9.4.2 Rest of World Autoimmune Drugs Revenue by Countries
9.4.3 Japan
9.4.4 Korea
9.4.5 India
9.4.6 Southeast Asia
10 Company Profiles
10.1 Eli Lilly
10.1.1 Eli Lilly Company Details
10.1.2 Company Description and Business Overview
10.1.3 Sales, Revenue and Market Share of Autoimmune Drugs
10.1.4 Autoimmune Drugs Product Introduction
10.1.5 Eli Lilly Recent Development
10.2 GSK
10.2.1 GSK Company Details
10.2.2 Company Description and Business Overview
10.2.3 Sales, Revenue and Market Share of Autoimmune Drugs
10.2.4 Autoimmune Drugs Product Introduction
10.2.5 GSK Recent Development
10.3 AbbVie
10.3.1 AbbVie Company Details
10.3.2 Company Description and Business Overview
10.3.3 Sales, Revenue and Market Share of Autoimmune Drugs
10.3.4 Autoimmune Drugs Product Introduction
10.3.5 AbbVie Recent Development
10.4 Johnson & Johnson
10.4.1 Johnson & Johnson Company Details
10.4.2 Company Description and Business Overview
10.4.3 Sales, Revenue and Market Share of Autoimmune Drugs
10.4.4 Autoimmune Drugs Product Introduction
10.4.5 Johnson & Johnson Recent Development
10.5 Biogen
10.5.1 Biogen Company Details
10.5.2 Company Description and Business Overview
10.5.3 Sales, Revenue and Market Share of Autoimmune Drugs
10.5.4 Autoimmune Drugs Product Introduction
10.5.5 Biogen Recent Development
10.6 Amgen
10.6.1 Amgen Company Details
10.6.2 Company Description and Business Overview
10.6.3 Sales, Revenue and Market Share of Autoimmune Drugs
10.6.4 Autoimmune Drugs Product Introduction
10.6.5 Amgen Recent Development
10.7 Pfizer
10.7.1 Pfizer Company Details
10.7.2 Company Description and Business Overview
10.7.3 Sales, Revenue and Market Share of Autoimmune Drugs
10.7.4 Autoimmune Drugs Product Introduction
10.7.5 Pfizer Recent Development
10.8 Roche
10.8.1 Roche Company Details
10.8.2 Company Description and Business Overview
10.8.3 Sales, Revenue and Market Share of Autoimmune Drugs
10.8.4 Autoimmune Drugs Product Introduction
10.8.5 Roche Recent Development
10.9 Baxter
10.9.1 Baxter Company Details
10.9.2 Company Description and Business Overview
10.9.3 Sales, Revenue and Market Share of Autoimmune Drugs
10.9.4 Autoimmune Drugs Product Introduction
10.9.5 Baxter Recent Development
11 Value Chain and Sales Channels Analysis
11.1 Value Chain Analysis
11.2 Sales Channels Analysis
11.2.1 Autoimmune Drugs Sales Channels
11.2.2 Autoimmune Drugs Distributors
11.3 Autoimmune Drugs Customers
12 Market Forecast
12.1 Global Autoimmune Drugs Sales and Revenue Forecast 2019-2025
12.2 Global Autoimmune Drugs Sales Forecast by Type
12.3 Global Autoimmune Drugs Sales Forecast by Application
12.4 Autoimmune Drugs Forecast by Regions
12.4.1 Global Autoimmune Drugs Sales Forecast by Regions 2019-2025
12.4.2 Global Autoimmune Drugs Revenue Forecast by Regions 2019-2025
12.5 United States Market Forecast
12.6 European Union Market Forecast
12.7 China Market Forecast
12.8 Rest of World
12.8.1 Japan
12.8.2 Korea
12.8.3 India
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer
